93 related articles for article (PubMed ID: 26149502)
1. Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein.
Zajkowski T; Nieznanska H; Nieznanski K
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2228-39. PubMed ID: 26149502
[TBL] [Abstract][Full Text] [Related]
2. Lithium alleviates neurotoxic prion peptide-induced synaptic damage and neuronal death partially by the upregulation of nuclear target REST and the restoration of Wnt signaling.
Song Z; Yang W; Zhou X; Yang L; Zhao D
Neuropharmacology; 2017 Sep; 123():332-348. PubMed ID: 28545972
[TBL] [Abstract][Full Text] [Related]
3. Molecular interaction of TPPP with PrP antagonized the CytoPrP-induced disruption of microtubule structures and cytotoxicity.
Zhou RM; Jing YY; Guo Y; Gao C; Zhang BY; Chen C; Shi Q; Tian C; Wang ZY; Gong HS; Han J; Xu BL; Dong XP
PLoS One; 2011; 6(8):e23079. PubMed ID: 21857997
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
[TBL] [Abstract][Full Text] [Related]
6. Tau inhibits tubulin oligomerization induced by prion protein.
Osiecka KM; Nieznanska H; Skowronek KJ; Jozwiak J; Nieznanski K
Biochim Biophys Acta; 2011 Oct; 1813(10):1845-53. PubMed ID: 21763357
[TBL] [Abstract][Full Text] [Related]
7. Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.
Pérez M; Rojo AI; Wandosell F; Díaz-Nido J; Avila J
Biochem J; 2003 May; 372(Pt 1):129-36. PubMed ID: 12578563
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of the PI3K-Akt-GSK-3 pathway is a common feature in cell culture and in vivo models of prion disease.
Simon D; Herva ME; Benitez MJ; Garrido JJ; Rojo AI; Cuadrado A; Torres JM; Wandosell F
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):311-26. PubMed ID: 23741998
[TBL] [Abstract][Full Text] [Related]
9. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of microtubule-associated proteins of MAP2/tau family in Prion disease.
Zhang J; Dong XP
Prion; 2012; 6(4):334-8. PubMed ID: 22874672
[TBL] [Abstract][Full Text] [Related]
12. Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly.
Osiecka KM; Nieznanska H; Skowronek KJ; Karolczak J; Schneider G; Nieznanski K
Proteins; 2009 Nov; 77(2):279-96. PubMed ID: 19422054
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin protects against prion protein-induced cell death in neuronal cells by preventing mitochondrial dysfunction.
Park YG; Jeong JK; Lee JH; Lee YJ; Seol JW; Kim SJ; Hur TY; Jung YH; Kang SJ; Park SY
Int J Mol Med; 2013 Feb; 31(2):325-30. PubMed ID: 23228942
[TBL] [Abstract][Full Text] [Related]
14. The GSK3-MAP1B pathway controls neurite branching and microtubule dynamics.
Barnat M; Benassy MN; Vincensini L; Soares S; Fassier C; Propst F; Andrieux A; von Boxberg Y; Nothias F
Mol Cell Neurosci; 2016 Apr; 72():9-21. PubMed ID: 26773468
[TBL] [Abstract][Full Text] [Related]
15. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
[TBL] [Abstract][Full Text] [Related]
17. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.
Last V; Williams A; Werling D
BMC Neurosci; 2012 Aug; 13():106. PubMed ID: 22928663
[TBL] [Abstract][Full Text] [Related]
19. Prion protein impairs kinesin-driven transport.
Nieznanska H; Dudek E; Zajkowski T; Szczesna E; Kasprzak AA; Nieznanski K
Biochem Biophys Res Commun; 2012 Sep; 425(4):788-93. PubMed ID: 22885185
[TBL] [Abstract][Full Text] [Related]
20. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126).
Perovic S; Schröder HC; Pergande G; Ushijima H; Müller WE
Exp Neurol; 1997 Oct; 147(2):518-24. PubMed ID: 9344576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
